Re. Yee et al., Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity inMPTP-treated squirrel monkeys: In vivo and in vitro investigations, J NEUROCHEM, 74(3), 2000, pp. 1147-1157
Aromatic L-amino acid decarboxylase (AAAD) activity was examined in vivo wi
th positron emission tomography (PET) using 6-[F-18]fluoro-L-DOPA (FDOPA) i
n squirrel monkeys lesioned with graded doses of the neurotoxin 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP). In vitro biochemical determinatio
ns of AAAD activity in caudate, putamen, substantia nigra, and nucleus accu
mbens were performed in the same animals to establish a direct comparison o
f in vivo and in vitro measurements. In vivo and in vitro AAAD activities i
n caudate/putamen were substantially reduced in animals treated with the hi
ghest dose of MPTP (2.0 mg/kg), The percent change in the striatal FDOPA up
take (K-i) and decarboxylation rate constant (k(3)) values resulting from M
PTP treatment showed highly significant correlations with in vitro-determin
ed AAAD activities. However, decarboxylase rates within individual animals
presented as similar to 10-fold difference between in vivo and in vitro val
ues. Lower in vivo k(3) measurements may be attributed to several possibili
ties, including transport restrictions limiting substrate availability to A
AAD within the neuron. In addition, reductions in AAAD activity in the subs
tantia nigra did not parallel reductions in AAAD activity within the striat
um, supporting the notion of a nonlinear relationship between nigrostriatal
cell degeneration and terminal losses. This work further explores the role
of AAAD in Parkinson's disease, a more important factor than previously th
ought.